FRIDAY, June 2, 2023 (HealthDay News) — A new liver dialysis device might soon be able to save patients on the edge of death from liver failure, early clinical trial results show. The DIALIVE device safely improved organ function and alleviated symptoms in patients with acute-on-chronic liver failure, compared withContinue Reading
WEDNESDAY, May 10, 2023 (HealthDay News) — Finding out that you or a loved one has chronic obstructive pulmonary disease (COPD) can be alarming and may leave you with a lot of questions. Though COPD has no cure, it’s a condition that can be managed with the right treatments andContinue Reading
WEDNESDAY, April 26, 2023 (HealthDay News) – The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The medication, toferson (Qalsody), targets a mutation in the SOD1-ALS gene. ALSContinue Reading
MONDAY, April 24, 2023 (HealthDay News) — If you have experienced a toothache, you know it’s no joke. That searing pain in your mouth can keep you from concentrating, getting adequate sleep and so much more. Plus, not treating the root cause of a toothache can lead to bigger problemsContinue Reading
WEDNESDAY, April 19, 2023 (HealthDay News) — When you mention arthritis, most people think of osteoarthritis, where aging and wear-and-tear on the joints take their toll, but there is another type of arthritis that causes devastating damage after your immune system starts attacking your joints. Rheumatoid arthritis is the mostContinue Reading
MONDAY, April 17, 2023 (HealthDay News) — Arthritis strikes millions of Americans, leaving them with aching, inflamed joints that make it hard to move around without pain. It is the leading cause of disability and most common in women, but is it the same for everyone? Absolutely not. There areContinue Reading
THURSDAY, Dec. 15, 2022 (HealthDay News) — Quitting alcohol can help reduce complications of liver cirrhosis, even in patients who have advanced disease. It can also help them live longer, new research shows. “Our results clearly show that all patients with alcohol-related liver cirrhosis who maintain sustained abstinence from alcoholContinue Reading
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Bees, in their role as master pollinators, increase crop yields, leading to more production of healthy fruits, vegetables and nuts. But new research claims that the challenges these important insects face from changes in land use, harmful pesticides and climate change is affectingContinue Reading
TUESDAY, Nov. 15, 2022 (HealthDay News) – Singer Roberta Flack has the incurable disease ALS and can’t sing, but she plans to stay active on other projects, her manager said Monday. Flack, 85, is a Grammy winner best known for hits that include “Killing Me Softly With His Song” andContinue Reading
THURSDAY, Oct. 20, 2022 (HealthDay News) — Researchers have made early progress toward a new approach to treating the deadly brain disease amyotrophic lateral sclerosis (ALS): using patients’ own immune system T cells. ALS is a rare condition that kills nerve cells in the brain and spinal cord that controlContinue Reading
FRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease. But approval of the drug, called Relyvrio, is bound to stir new questions, with some doubting theContinue Reading
MONDAY, Sept. 26, 2022 (HealthDay News) — People who work in manufacturing, welding and chemical operations and are exposed to hazardous chemicals may face a higher risk of developing amyotrophic lateral sclerosis (ALS), a new study found. “This study shows that certain occupational settings and exposures increase one’s chances ofContinue Reading
FRIDAY, Sept. 23, 2022 (HealthDay News) — People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows. The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leadsContinue Reading
THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its advisors’ recommendations, though it usually does. Wednesday’s vote was 7-2Continue Reading